Subclinical hypothyroidism (SCH) often goes unnoticed, yet its implications span cardiovascular risk, pregnancy outcomes, and long-term metabolic health. This video explores the prevalence of SCH in India, its silent presentation, and evolving evidence linking SCH with coronary artery disease. It also walks through a practical, evidence-based treatment algorithm, with special considerations for pregnant and elderly patients, anti-TPO status, and follow-up strategies. In your practice, when do you decide to initiate treatment versus observe and follow up?
##Sources## Subclinical hypothyroidism in adults: Consensus statement of Indian Thyroid Society (2022). Thyroid disorders in pregnancy: Consensus statement of Indian Thyroid Society (2021). Chowdhury SR, Mandal TK, and Mukhopadhyay P. A Study Correlating the Effects of Subclinical Hypothyroidism on the Known Modifiable Risk Factors of…
